image: SEMA/SNAC passing through epithelial cells to blood vessels where it can be absorbed and work to lower blood glucose and body weight. This material relates to a paper that appeared in the Nov. 14, 2018, issue of Science Translational Medicine, published by AAAS. The paper, by S.T. Buckley at ovo Nordisk A/S in Måløv, Denmark; and colleagues was titled, " Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist." view more
Credit: Stephen T Buckley